Peritoneal NGAL: a reliable biomarker for PD-peritonitis monitoring
J Nephrol
.
2023 Sep;36(7):2139-2141.
doi: 10.1007/s40620-022-01547-y.
Epub 2023 Jan 17.
Authors
Grazia Maria Virzì
#
1
2
,
Maria Mattiotti
#
3
4
5
,
Sabrina Milan Manani
3
4
,
Maddalena Gnappi
3
4
6
,
Ilaria Tantillo
3
4
,
Valentina Corradi
3
4
,
Massimo de Cal
3
4
,
Anna Giuliani
3
4
,
Mariarosa Carta
6
,
Davide Giavarina
7
,
Claudio Ronco
3
4
6
,
Monica Zanella
3
4
Affiliations
1
Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Via Rodolfi, 37, 36100, Vicenza, Italy.
[email protected]
.
2
IRRIV-International Renal Research Institute, Vicenza, Italy.
[email protected]
.
3
Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Via Rodolfi, 37, 36100, Vicenza, Italy.
4
IRRIV-International Renal Research Institute, Vicenza, Italy.
5
Nephrology, Dialysis and Transplant Unit, IRCCS Policlinico Sant'Orsola, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
6
DIMED, University of Padova, Padua, Italy.
7
Department of Clinical Chemistry and Hematology Laboratory, San Bortolo Hospital, Vicenza, Italy.
#
Contributed equally.
PMID:
36646971
DOI:
10.1007/s40620-022-01547-y
No abstract available
Keywords:
Neutrophil gelatinase-associated lipocalin; Outcome; Peritoneal dialysis; Peritonitis.
Publication types
Letter
MeSH terms
Biomarkers
Humans
Lipocalin-2
Peritoneum*
Peritonitis* / diagnosis
Substances
Lipocalin-2
Biomarkers